Latest News for: il-23

Edit

European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor

Pharmiweb 19 Dec 2025
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases ... Atreya, R, et al. Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling. J Crohns Colitis. 2024;18(suppl).S470.
Edit

Nadda appoints Sanjay Saraogi as new Bihar BJP president

The Hindu 15 Dec 2025
The 56-year-old leader is five times MLA hails from the Vaishya community, which is the core voter of the party. He earlier served as the coordinator of the Bihar State BJP Cow Protection Cell ....
Edit

‘You executed him’: Tijuana man sentenced to life for hostage-taking killing of San Diego teen

The San Diego Union-Tribune 11 Dec 2025
San Diego resident Miguel Anthony Rendon was just 18 years old when he was abducted, tortured and killed in May 2020 by a group of young men in Tijuana ... On Wednesday, U.S ... “You executed him … It was cold-blooded,” Hayes said.
Edit

Labour Together director donates £100k to leadership contenders

The Daily Telegraph 11 Dec 2025
A director of a think tank that helped steer Sir Keir Starmer to power has donated £100,000 to potential Labour leadership contenders ... Others included Bridget Phillipson, Ed Miliband and Darren Jones ... Join the conversation. Show comments ... Copy link ... .
Edit

Paddington musical in the West End is practically paw-fect, say theatre critics

The Guardian 01 Dec 2025
Michael Bond’s beloved bear is the star of an eagerly anticipated new show at the Savoy theatre in London. Here is what the critics thought. Paddington is brought to life with state-of-the-art animatronics ... Arifa Akbar, the Guardian ... Ah, Paddington Bear.
Edit

New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis (Johnson & Johnson)

Public Technologies 17 Nov 2025
TREMFYA® is the first and only fully-human, dual-acting monoclonal antibody approved to treat PsA that blocks IL-23 while also binding to CD64, a receptor on cells that produce IL-23 ... produce IL-23).
Edit

New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis

PR Newswire 17 Nov 2025
TREMFYA® is the first and only fully-human, dual-acting monoclonal antibody approved to treat PsA that blocks IL-23 while also binding to CD64, a receptor on cells that produce IL-23 ... IL-23).
Edit

Tremfya Market Research Report 2025: Increasing Adoption of IL-23 Inhibitors and Rising Prevalence of Chronic ...

Nasdaq Globe Newswire 11 Nov 2025
Opportunities include its high efficacy and safety, growing prevalence of diseases, and pharmaceutical investment in new indications ... .
Edit

Ravindra Jadeja to bid adieu, CSK set to welcome Sanju Samson; Trade deal 48 hours ...

Hindustan Times 11 Nov 2025
Chennai Super Kings and the Rajasthan Royals are pushing ahead with a sensational player swap involving Ravindra Jadeja, Sam Curran, and Sanju Samson, but the deal is still stuck in the regulatory lane ... Latest update on the trade ... Also Read ... Report ... ....
Edit

Musk could become history’s first trillionaire as Tesla shareholders approve giant pay package

Waurika News Journal 06 Nov 2025
By BERNARD CONDON. NEW YORK (AP) — The world’s richest man was just handed a chance to become history’s first trillionaire. Related Articles. Peloton recalls nearly 878,000 exercise bikes after several seat posts break ... Here’s what travelers can expect.
Edit

Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody

Nasdaq Globe Newswire 04 Nov 2025
SPY003 was well tolerated and exhibited an ~85-day half-life, supporting potential quarterly or twice annual maintenance dosing ... .
Edit

TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years

PR Newswire 27 Oct 2025
People who have a genetic problem where the body does not make any of the proteins interleukin 12 (IL-12) and interleukin 23 (IL-23) are at a higher risk for certain serious infections that can spread throughout the body and cause death.
Edit

ALCS: Max Scherzer, Blue Jays crush Mariners in Game 4 to even series

Orange County Register 17 Oct 2025
By ANDREW DESTIN AP Sports Writer ... Vladimir Guerrero Jr ... Game 5 in the best-of-seven series is Friday (3 p.m. PT, FS1), with Kevin Gausman scheduled to start for Toronto against Game 1 winner Bryce Miller ... UP NEXT ... More to come on this story. .
×